Champions Oncology (CSBR) FCF Margin Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | -3,088.00 |
| 10 | Champions Oncology | 67.95 Mn | 67.95 Mn | 7.03 Mn | -506.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -506.00 |
| Jan 31, 2026 | -1,472.00 |
| Oct 31, 2025 | -3,033.00 |
| Jul 31, 2025 | 915.00 |
| Apr 30, 2025 | 5,365.00 |
| Jan 31, 2025 | -2,828.00 |
| Oct 31, 2024 | -841.00 |
| Jul 31, 2024 | 835.00 |
| Apr 30, 2024 | 1,388.00 |
| Jan 31, 2024 | 147.00 |
| Oct 31, 2023 | 72.00 |
| Jul 31, 2023 | -2,208.00 |
| Apr 30, 2023 | -2,275.00 |
| Jan 31, 2023 | 521.00 |
| Oct 31, 2022 | 1,108.00 |
| Jul 31, 2022 | 835.00 |
| Apr 30, 2022 | 81.00 |
| Jan 31, 2022 | 1,360.00 |
| Oct 31, 2021 | 877.00 |
| Jul 31, 2021 | -815.00 |